martes, 16 de febrero de 2016

National Guideline Clearinghouse | ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors.

National Guideline Clearinghouse | ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors.



National Guideline Clearinghouse (NGC)

American College of Radiology


Guideline Title
ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors.
Bibliographic Source(s)
Roberts CC, Kransdorf MJ, Beaman FD, Adler RS, Amini B, Appel M, Bernard SA, Fries IB, Germano IM, Greenspan BS, Holly LT, Kubicky CD, Lo SS, Mosher TJ, Sloan AE, Tuite MJ, Walker EA, Ward RJ, Wessell DE, Weissman BN, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors. Reston (VA): American College of Radiology (ACR); 2015. 15 p. [83 references]
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Fitzgerald JJ, Roberts CC, Daffner RH, Weissman BN, Appel M, Bancroft L, Bennett DL, Blebea JS, Bruno MA, Fries IB, Germano IM, Hayes CW, Holly L, Kransdorf MJ, Luchs JS, Morrison WB, Olson JJ, Scharf SC, Stoller DW, Taljanovic MS, Tuite MJ, Ward RJ, Wise JN, Zoga AC, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® follow-up of malignant or aggressive musculoskeletal tumors. [online publication]. Reston (VA): American College of Radiology (ACR); 2011. 13 p. [55 references]
This guideline meets NGC's 2013 (revised) inclusion criteria

No hay comentarios:

Publicar un comentario